title: Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000).
authors.forename: D E
authors.initials: DE
authors.lastname: Furst
authors.forename: F C
authors.initials: FC
authors.lastname: Breedveld
authors.forename: G R
authors.initials: GR
authors.lastname: Burmester
authors.forename: J J
authors.initials: JJ
authors.lastname: Crofford
authors.forename: P
authors.initials: P
authors.lastname: Emery
authors.forename: M
authors.initials: M
authors.lastname: Feldmann
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: A F
authors.initials: AF
authors.lastname: Kavanaugh
authors.forename: E C
authors.initials: EC
authors.lastname: Keystone
authors.forename: L G
authors.initials: LG
authors.lastname: Klareskog
authors.forename: P E
authors.initials: PE
authors.lastname: Lipsky
authors.forename: R N
authors.initials: RN
authors.lastname: Maini
authors.forename: A S
authors.initials: AS
authors.lastname: Russell
authors.forename: D L
authors.initials: DL
authors.lastname: Scott
authors.forename: J S
authors.initials: JS
authors.lastname: Smolen
authors.forename: L B
authors.initials: LB
authors.lastname: Van de Putte
authors.forename: T L
authors.initials: TL
authors.lastname: Visher
authors.forename: M H
authors.initials: MH
authors.lastname: Weisman
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha